» Articles » PMID: 18243111

Cooperative Assembly of TGF-beta Superfamily Signaling Complexes is Mediated by Two Disparate Mechanisms and Distinct Modes of Receptor Binding

Overview
Journal Mol Cell
Publisher Cell Press
Specialty Cell Biology
Date 2008 Feb 5
PMID 18243111
Citations 149
Authors
Affiliations
Soon will be listed here.
Abstract

Dimeric ligands of the transforming growth factor-beta (TGF-beta) superfamily signal across cell membranes in a distinctive manner by assembling heterotetrameric complexes of structurally related serine/threonine-kinase receptor pairs. Unlike complexes of the bone morphogenetic protein (BMP) branch that apparently form due to avidity from membrane localization, TGF-beta complexes assemble cooperatively through recruitment of the low-affinity (type I) receptor by the ligand-bound high-affinity (type II) pair. Here we report the crystal structure of TGF-beta3 in complex with the extracellular domains of both pairs of receptors, revealing that the type I docks and becomes tethered via unique extensions at a composite ligand-type II interface. Disrupting the receptor-receptor interactions conferred by these extensions abolishes assembly of the signaling complex and signal transduction (Smad activation). Although structurally similar, BMP and TGF-beta receptors bind in dramatically different modes, mediating graded and switch-like assembly mechanisms that may have coevolved with branch-specific groups of cytoplasmic effectors.

Citing Articles

Structures of TGF-β with betaglycan and signaling receptors reveal mechanisms of complex assembly and signaling.

Wieteska L, Taylor A, Punch E, Coleman J, Conway I, Lin Y Nat Commun. 2025; 16(1):1778.

PMID: 40011426 PMC: 11865472. DOI: 10.1038/s41467-025-56796-9.


TGM6 is a helminth secretory product that mimics TGF-β binding to TGFBR2 to antagonize signaling in fibroblasts.

White S, Schwartze T, Mukundan A, Schoenherr C, Singh S, van Dinther M Nat Commun. 2025; 16(1):1847.

PMID: 39984487 PMC: 11845725. DOI: 10.1038/s41467-025-56954-z.


The TGF-β mimic TGM4 achieves cell specificity through combinatorial surface co-receptor binding.

Singh S, Smyth D, Cunningham K, Mukundan A, Byeon C, Hinck C EMBO Rep. 2024; 26(1):218-244.

PMID: 39609640 PMC: 11723922. DOI: 10.1038/s44319-024-00323-2.


Comprehensive molecular interaction map of TGFβ induced epithelial to mesenchymal transition in breast cancer.

Gottumukkala S, Ganesan T, Palanisamy A NPJ Syst Biol Appl. 2024; 10(1):53.

PMID: 38760412 PMC: 11101644. DOI: 10.1038/s41540-024-00378-w.


vNARs as Neutralizing Intracellular Therapeutic Agents: Glioblastoma as a Target.

Manzanares-Guzman A, Lugo-Fabres P, Camacho-Villegas T Antibodies (Basel). 2024; 13(1).

PMID: 38534215 PMC: 10967338. DOI: 10.3390/antib13010025.